HISA Issues Updated Withdrawal Guidance For Phenylbutazone

The Anti-Doping and Medication Control (ADMC) program has proposed enforcing the screening limit of phenylbutazone at 300 ng/mL in blood, rather than the previously established screening limit of 200 ng/mL in blood. HISA will file Guidance with the Federal Trade Commission that will implement this change in the enforcement of the screening limit. The RMTC's Scientific Advisory Committee (SAC) has been asked by industry stakeholders to review its withdrawal guidance of phenylbutazone based upon the updated proposed screening limit. Based on the updated screening limit of 300 ng/mL in blood and a single IV dose of 4.4 mg/kg, the SAC has reviewed all available data and is now recommending an updated withdrawal guidance of 72 hours for phenylbutazone. The RMTC's Withdrawal Guidance of HISA's ADMC Detection Times document will reflect those changes.

The post HISA Issues Updated Withdrawal Guidance For Phenylbutazone appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Travel Issues Derail Prosperous Voyage’s Saint-Alary Bid

Ralph Beckett trainee Prosperous Voyage (Ire) (Zoffany {Ire}) has been withdrawn from Sunday's G1 St Mark's Basilica Coolmore Prix Saint-Alary due to travel issues en route to France. Second in the G1 QIPCO 1000 Guineas on May 1, the filly and Beckett's staff are stranded in Dover. The market leader for the 10-furlong contest prior to her defection, the race is now wide open and sees Charlie Appleby and Godolphin hunting for their second edition of the race with Wild Beauty (GB) (Frankel {GB}). Appleby saddled Sobetsu (GB) (Dubawi {Ire}) to win in 2017.

The post Travel Issues Derail Prosperous Voyage’s Saint-Alary Bid appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights